Combination therapy in naive patients with chronic hepatitis C: more value for the money.
Koff
R S
RS
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005060:Europe; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D013030:Spain
D000998:Antiviral Agents